Učitavanje...
Cannabinoid type 1 receptor antagonists for smoking cessation
BACKGROUND: Selective type 1 cannabinoid (CB1) receptor antagonists may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. They also seek to address many smokers' reluctance to persist with a quit attempt be...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2011
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486173/ https://ncbi.nlm.nih.gov/pubmed/21412887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005353.pub4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|